Tieni traccia delle ultime attività di insider trading Annexon. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Annexon.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
A Annexon Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori non hanno segnalato vendite negli ultimi 30 giorni, mentre gli addetti ai lavori hanno segnalato di aver acquistato un totale di 4.12K azioni per un valore totale di $12.55K.
Oct 02, 2025 | — | 4.12K | $3.05 | $12.55K | BUY | 10.84% | 42.06K | Sep 30 | ||
Sep 04, 2025 | — | 4.12K | $2.09 | $8.60K | BUY | 12.16% | 37.95K | Sep 02 | ||
Aug 01, 2025 | — | 4.12K | $2.43 | $10.00K | BUY | 13.85% | 33.83K | Jul 30 | ||
Jul 16, 2025 | EVP & CHIEF INNOVATION OFFICER | -1.12K | $2.58 | -$2.88K | SELL | -1.05% | 105.08K | Jul 14 | ||
Jul 16, 2025 | EVP & CHIEF FINANCIAL OFFICER | -1.12K | $2.58 | -$2.88K | SELL | -0.91% | 121.62K | Jul 14 | ||
Jul 16, 2025 | EVP & CHIEF BUSINESS OFFICER | -853.00 | $2.61 | -$2.23K | SELL | -0.65% | 130.69K | Jul 14 | ||
Jul 01, 2025 | — | 4.12K | $2.46 | $10.12K | BUY | 16.07% | 29.71K | Jun 30 | ||
Feb 20, 2025 | CHIEF MEDICAL OFFICER | -5.52K | $2.96 | -$16.34K | SELL | -14.16% | 33.48K | Feb 18 | ||
Feb 20, 2025 | EVP & CHIEF SCIENTIFIC OFFICER | -5.51K | $2.97 | -$16.38K | SELL | -6.17% | 83.81K | Feb 18 | ||
Feb 20, 2025 | EVP & CHIEF INNOVATION OFFICER | -8.35K | $2.91 | -$24.28K | SELL | -11.99% | 61.24K | Feb 18 | ||
Feb 20, 2025 | EVP & CHIEF BUSINESS OFFICER | -6.62K | $2.95 | -$19.52K | SELL | -7.10% | 86.58K | Feb 18 | ||
Feb 20, 2025 | EVP & CHIEF FINANCIAL OFFICER | -6.91K | $2.92 | -$20.18K | SELL | -8.16% | 77.77K | Feb 18 | ||
Feb 18, 2025 | PRESIDENT AND CEO | -5.02K | $2.95 | -$14.81K | SELL | -1.41% | 351.55K | Feb 13 | ||
Feb 18, 2025 | EVP & CHIEF FINANCIAL OFFICER | -1.79K | $2.98 | -$5.32K | SELL | -2.07% | 84.68K | Feb 13 | ||
Feb 18, 2025 | EVP & CHIEF BUSINESS OFFICER | -1.43K | $2.99 | -$4.26K | SELL | -1.51% | 93.20K | Feb 13 | ||
Feb 18, 2025 | EVP & CHIEF INNOVATION OFFICER | -1.78K | $2.99 | -$5.33K | SELL | -2.50% | 69.58K | Feb 13 | ||
Dec 04, 2024 | — | 3.20K | $5.33 | $17.06K | BUY | 14.29% | 25.60K | Dec 02 | ||
Oct 17, 2024 | EVP & CHIEF INNOVATION OFFICER | 0.00 | $4.63 | -$30.07K | SELL-OPTIONS | 0.00% | 71.36K | Oct 15 | ||
Oct 02, 2024 | — | 3.20K | $5.97 | $19.10K | BUY | 16.67% | 22.40K | Oct 01 | ||
Sep 20, 2024 | EVP & CHIEF INNOVATION OFFICER | -4.50K | $7.10 | -$31.95K | SELL | -5.93% | 71.36K | Sep 19 | ||
Sep 16, 2024 | EVP & CHIEF INNOVATION OFFICER | -5.50K | $6.16 | -$33.88K | SELL | -6.76% | 75.86K | Sep 12 | ||
Sep 06, 2024 | EVP & CHIEF INNOVATION OFFICER | -5.50K | $5.64 | -$31.02K | SELL | -6.33% | 81.36K | Sep 05 | ||
Sep 04, 2024 | — | 3.20K | $5.48 | $17.54K | BUY | 20.00% | 19.20K | Sep 03 | ||
Aug 30, 2024 | EVP & CHIEF INNOVATION OFFICER | -5.50K | $5.95 | -$32.73K | SELL | -5.95% | 86.86K | Aug 29 | ||
Aug 05, 2024 | — | 3.20K | $6.24 | $19.97K | BUY | 25.00% | 16.00K | Aug 01 | ||
Jul 17, 2024 | EVP & CHIEF BUSINESS OFFICER | -784.00 | $6.02 | -$4.72K | SELL | -0.82% | 94.62K | Jul 15 | ||
Jul 17, 2024 | EVP & CHIEF FINANCIAL OFFICER | -1.10K | $6.03 | -$6.66K | SELL | -1.26% | 86.47K | Jul 15 | ||
Jul 17, 2024 | EVP & CHIEF INNOVATION OFFICER | -1.11K | $6.02 | -$6.66K | SELL | -1.18% | 92.36K | Jul 15 | ||
Jul 02, 2024 | — | 3.20K | $5.00 | $16.00K | BUY | 33.33% | 12.80K | Jul 01 | ||
Jun 05, 2024 | — | 3.20K | $4.83 | $15.46K | BUY | 50.00% | 9.60K | Jun 03 | ||
May 03, 2024 | — | 3.20K | $4.68 | $14.98K | BUY | 100.00% | 6.40K | May 01 | ||
Apr 10, 2024 | — | 3.20K | $6.07 | $19.41K | BUY | ∞ | 3.20K | Apr 08 | ||
Feb 21, 2024 | EVP & CHIEF FINANCIAL OFFICER | 36.41K | $5.53 | -$14.34K | GRANT | 79.75% | 82.06K | Feb 16 - Feb 20 | ||
Feb 21, 2024 | EVP & CHIEF INNOVATION OFFICER | 36.40K | $5.51 | -$14.35K | GRANT | 63.77% | 93.47K | Feb 16 - Feb 20 | ||
Feb 21, 2024 | EVP & CHIEF BUSINESS OFFICER | 37.05K | $5.48 | -$10.69K | GRANT | 76.25% | 85.64K | Feb 16 - Feb 20 | ||
Feb 14, 2024 | EVP & CHIEF BUSINESS OFFICER | -1.35K | $5.53 | -$7.46K | SELL | -2.70% | 48.59K | Feb 12 | ||
Feb 14, 2024 | PRESIDENT AND CEO | -5.78K | $5.54 | -$32.03K | SELL | -2.86% | 196.12K | Feb 12 | ||
Feb 14, 2024 | EVP & CHIEF FINANCIAL OFFICER | -1.81K | $5.54 | -$10.02K | SELL | -3.81% | 45.65K | Feb 12 | ||
Feb 14, 2024 | EVP & CHIEF INNOVATION OFFICER | -1.81K | $5.54 | -$10.03K | SELL | -3.07% | 57.08K | Feb 12 | ||
Jan 23, 2024 | EVP & CHIEF BUSINESS OFFICER | -978.00 | $3.84 | -$3.75K | SELL | -2.09% | 45.80K | Jul 11 | ||
Jan 23, 2024 | EVP & CHIEF FINANCIAL OFFICER | -1.06K | $3.84 | -$4.05K | SELL | -2.18% | 47.46K | Jul 11 | ||
Dec 29, 2023 | EVP & CHIEF INNOVATION OFFICER | 0.00 | $3.07 | -$60.79K | SELL-OPTIONS | 0.00% | 0.00 | Dec 27 | ||
Dec 28, 2023 | DIRECTOR | 350.00K | $2.88 | $1.01M | BUY | 4.96% | 7.41M | Dec 26 | ||
May 30, 2023 | 10% OWNER | 300.00K | $2.13 | $639.72K | BUY | 5.55% | 5.70M | May 25 | ||
Feb 17, 2023 | PRESIDENT & CEO | -6.57K | $5.87 | -$38.56K | SELL | -3.22% | 197.65K | Feb 15 | ||
Feb 15, 2023 | EVP & CHIEF BUSINESS OFFICER | -1.65K | $6.30 | -$10.37K | SELL | -5.59% | 27.80K | Feb 13 - Feb 14 | ||
Feb 15, 2023 | EVP & CHIEF FINANCIAL OFFICER | -1.91K | $6.31 | -$12.04K | SELL | -6.07% | 29.54K | Feb 13 - Feb 14 | ||
Feb 14, 2023 | DIRECTOR | 2.65M | $6.80 | $18.00M | BUY | 60.04% | 7.06M | Feb 10 | ||
Jul 11, 2022 | DIRECTOR | 2.45M | $3.84 | $9.42M | BUY | 125.53% | 4.41M | Jul 07 | ||
Apr 18, 2022 | PRESIDENT & CEO | 60.00K | $2.45 | $146.81K | BUY | 42.57% | 200.94K | Apr 14 | ||
Sep 20, 2021 | PRESIDENT & CEO | 0.00 | $11.73 | -$154.77K | SELL-OPTIONS | 0.00% | 0.00 | Sep 16 | ||
Sep 15, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $10.84 | -$296.64K | SELL-OPTIONS | 0.00% | 0.00 | Sep 13 | ||
Sep 15, 2021 | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $13.75 | -$43.82K | SELL-OPTIONS | 0.00% | 2.00K | Sep 13 | ||
Jun 09, 2021 | PRESIDENT & CEO | 0.00 | $11.92 | -$157.66K | SELL-OPTIONS | 0.00% | 0.00 | Jun 07 - Jun 08 | ||
Jun 07, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $11.45 | -$301.18K | SELL-OPTIONS | 0.00% | 0.00 | Jun 03 | ||
Jun 01, 2021 | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $14.86 | -$51.63K | SELL-OPTIONS | 0.00% | 2.00K | May 27 | ||
Apr 02, 2021 | PRESIDENT & CEO | 0.00 | $14.76 | -$202.95K | SELL-OPTIONS | 0.00% | 0.00 | Mar 31 - Apr 01 | ||
Mar 31, 2021 | PRESIDENT & CEO | 0.00 | $13.19 | -$176.73K | SELL-OPTIONS | 0.00% | 0.00 | Mar 29 - Mar 30 | ||
Mar 29, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $15.24 | -$438.62K | SELL-OPTIONS | 0.00% | 0.00 | Mar 25 | ||
Mar 26, 2021 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $18.83 | -$90.60K | SELL-OPTIONS | 0.00% | 0.00 | Mar 24 | ||
Mar 25, 2021 | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $17.96 | -$104.73K | SELL-OPTIONS | 0.00% | 2.00K | Mar 23 |
Sfoglia insider trading su tutte le azioni.